Intetics’ Post

https://lnkd.in/e-UZaKiQ Remember the webinar on #artificialintelligence for #clinicaltrials Robert Zambon and myself did with pharmaphorum earlier this month? Good news: the recording is now available to all. So in case you want to listen once more to our inspired conversation or want to catch up on what you missed, here’s the link! I look forward to hearing your thoughts and feedback below in the comments. If you are interested to discuss how we at Syneos Health can leverage our #aitools to supercharge your clinical trial, click the ‘Get in Touch’ in the link.

Artificial Intelligence (AI) has the exciting potential to accelerate Clinical Research. This also will ask courage of us all to experiment with AI, learn and improve... Here's a glimpse into how AI is revolutionizing the landscape: 1.    Accelerated Drug Discovery: AI-driven algorithms analyze vast datasets to predict drug-target interactions, expediting the identification and validation of potential compounds, ultimately streamlining the drug discovery process. 2.    Precision Medicine and Personalized Treatment: AI empowers researchers to analyze genetic, molecular, and clinical data to identify biomarkers, enabling the development of personalized therapies tailored to individual patient profiles, enhancing treatment efficacy. 3.    Enhanced Clinical Trial Design: AI algorithms optimize trial design by identifying suitable patient populations, predicting patient responses, and refining protocols, leading to more efficient trials with improved success rates. 4.    Real-time Data Analysis: AI enables real-time analysis of patient data, facilitating remote monitoring, early detection of adverse events, and dynamic adjustments in treatment strategies, ensuring quicker interventions and better patient outcomes. 5.    Predictive Analytics for Patient Recruitment: Leveraging machine learning models assists in identifying eligible candidates for clinical trials based on comprehensive patient profiles, enhancing recruitment efficiency and diversifying participant pools. The integration of AI in Clinical Research isn't just a trend; it's a game-changer, reshaping how we approach research and patient care. Curious to learn more about how AI is revolutionizing our field? Let's connect and explore this fascinating intersection further. #AI #ClinicalResearch Also watch last months's interesting Syneos webinar on AI supercharging clinical research;

AI in Clinical Trials is not coming, it’s already here! This recorded Webinar is definitely worth a watch:

The clinical development market faces significant challenges, with rising 💰 costs and development ⌛time, increasing regulatory requirements and low success rates. These challenges highlight the pressing need to advance and improve the efficiency and preciseness of clinical development. 💫 Check this out PhaseV is a technology company innovating clinical development through advanced AI/ML technology. Leveraging proprietary causal machine learning and AI tools and cutting-edge software capabilities, PhaseV's platform enables sponsors to harness all available data to inform crucial decisions in clinical development and design and execute advanced adaptive clinical trials, leading to more efficient, precise, and successful clinical trials. In less than 2 years since its foundation, the company has proven its capabilities and unique value through over 20 customer projects, including with 7 of the 12 top big pharma companies successfully optimizing the clinical development path across multiple therapeutic areas. Dr. Raviv Pryluk, CEO & co-founder will be in San Francisco for the JPM Conference and is looking for more partners and investors who are interested in developing these capabilities and providing a better service to the industry. 📄Please fill out this form if you want to meet with PhaseV team: https://lnkd.in/d7fYjnax 📧 We would be happy to send you more information about the company's offerings, just send us an email to [email protected] #investmentopportunity #digitalhealth #softwaredevelopment Michal Landesman Elad Berkman LionBird Viola Ventures Exor Ventures Sharon Vanek #jpmc25

Generative AI-driven clinical trial: A myth or a reality? 💻🧠 At #DIA2024, Jonathan Shough, Parexel's Chief Information Officer, presented with other industry experts on how generative #AI can transform the clinical workflow, driving faster patient recruitment and efficient site selection or trial conduct. By diagnosing current challenges hampering clinical development, Jonathan and the panelists presented use cases and an outlook for AI-driven clinical solutions. Jonathan's leadership in the development of innovative technologies and solutions to accelerate drug development initiatives in a constantly evolving clinical trial landscape is inspiring and continues to provide efficiencies for our company and clients. 👏👏 #DIA #ClinicalReseach #ClinicalTechnology #Innovation

Generative AI-driven clinical trial: A myth or a reality? 💻🧠 At #DIA2024, Jonathan Shough, Parexel's Chief Information Officer, presented with other industry experts on how generative #AI can transform the clinical workflow, driving faster patient recruitment and efficient site selection or trial conduct. By diagnosing current challenges hampering clinical development, Jonathan and the panelists presented use cases and an outlook for AI-driven clinical solutions. Jonathan's leadership in the development of innovative technologies and solutions to accelerate drug development initiatives in a constantly evolving clinical trial landscape is inspiring and continues to provide efficiencies for our company and clients. 👏👏 #DIA #ClinicalReseach #ClinicalTechnology #Innovation

Generative AI-driven clinical trial: A myth or a reality? 💻🧠 At #DIA2024, Jonathan Shough, Parexel's Chief Information Officer, presented with other industry experts on how generative #AI can transform the clinical workflow, driving faster patient recruitment and efficient site selection or trial conduct. By diagnosing current challenges hampering clinical development, Jonathan and the panelists presented use cases and an outlook for AI-driven clinical solutions. Jonathan's leadership in the development of innovative technologies and solutions to accelerate drug development initiatives in a constantly evolving clinical trial landscape is inspiring and continues to provide efficiencies for our company and clients. 👏👏 #DIA #ClinicalReseach #ClinicalTechnology #Innovation

Generative AI-driven clinical trial: A myth or a reality? 💻🧠 At #DIA2024, Jonathan Shough, Parexel's Chief Information Officer, presented with other industry experts on how generative #AI can transform the clinical workflow, driving faster patient recruitment and efficient site selection or trial conduct. By diagnosing current challenges hampering clinical development, Jonathan and the panelists presented use cases and an outlook for AI-driven clinical solutions. Jonathan's leadership in the development of innovative technologies and solutions to accelerate drug development initiatives in a constantly evolving clinical trial landscape is inspiring and continues to provide efficiencies for our company and clients. 👏👏 #DIA #ClinicalReseach #ClinicalTechnology #Innovation

Generative AI-driven clinical trial: A myth or a reality? 💻🧠 At #DIA2024, Jonathan Shough, Parexel's Chief Information Officer, presented with other industry experts on how generative #AI can transform the clinical workflow, driving faster patient recruitment and efficient site selection or trial conduct. By diagnosing current challenges hampering clinical development, Jonathan and the panelists presented use cases and an outlook for AI-driven clinical solutions. Jonathan's leadership in the development of innovative technologies and solutions to accelerate drug development initiatives in a constantly evolving clinical trial landscape is inspiring and continues to provide efficiencies for our company and clients. 👏👏 #DIA #ClinicalReseach #ClinicalTechnology #Innovation

Generative AI-driven clinical trial: A myth or a reality? 💻🧠 At #DIA2024, Jonathan Shough, Parexel's Chief Information Officer, presented with other industry experts on how generative #AI can transform the clinical workflow, driving faster patient recruitment and efficient site selection or trial conduct. By diagnosing current challenges hampering clinical development, Jonathan and the panelists presented use cases and an outlook for AI-driven clinical solutions. Jonathan's leadership in the development of innovative technologies and solutions to accelerate drug development initiatives in a constantly evolving clinical trial landscape is inspiring and continues to provide efficiencies for our company and clients. 👏👏 #DIA #ClinicalReseach #ClinicalTechnology #Innovation